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The loss of protein homeostasis that has been associated with aging leads to altered
levels and conformational instability of proteins, which tend to form toxic aggregates. In
particular, brain aging presents characteristic patterns of misfolded oligomers, primarily
constituted of β-amyloid (Aβ), tau, and α-synuclein (α-syn), which can accumulate in
neuronal membranes or extracellular compartments. Such aging-related proteins can
also reach peripheral compartments, thus suggesting the possibility to monitor their
accumulation in more accessible fluids. In this respect, we have demonstrated that
α-syn forms detectable hetero-aggregates with Aβ or tau in red blood cells (RBCs)
of healthy subjects. In particular, α-syn levels and its heteromeric interactions are
modulated by plasma antioxidant capability (AOC), which increases in turn with physical
activity. In order to understand if a specific distribution of misfolded proteins can occur
in other blood cells, a cohort of human subjects was enrolled to establish a correlation
among AOC, the level of physical exercise and the concentrations of aging-related
proteins in platelets. The healthy subjects were divided depending on their level of
physical exercise (i.e., athletes and sedentary subjects) and their age (young and older
subjects). Herein, aging-related proteins (i.e., α-syn, tau and Aβ) were confirmed to
be present in human platelets. Among such proteins, platelet tau concentration was
demonstrated to decrease in athletes, while α-syn and Aβ did not correlate with physical
exercise. For the first time, α-syn was shown to directly interact with Aβ and tau in
platelets, forming detectable hetero-complexes. Interestingly, α-syn interaction with tau
was inversely related to plasma AOC and to the level of physical activity. These results
suggested that α-syn heterocomplexes, particularly with tau, could represent novel
indicators to monitor aging-related proteins in platelets.
Keywords: protein misfolding, α-synuclein, β-amyloid, tau, α-synuclein heterocomplexes, platelets, antioxidant
capability, physical exercise
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INTRODUCTION
Aging is characterized by a gradual decline of the protein
homeostasis (proteostasis) network, which affects the levels
and conformational stability of proteins (Díaz-Villanueva et al.,
2015; Labbadia and Morimoto, 2015), causing the formation of
misfolded and toxic aggregates (Lindner and Demarez, 2009;
Morimoto and Cuervo, 2014; Tan et al., 2014; Labbadia and
Morimoto, 2015), and ultimately cell death.
Misfolded and oligomeric proteins appear to spread through
the brain in characteristic, with robust evidence for the increase of
beta amyloid1−42 (Aβ), tau, and α-synuclein (α-syn) (Jucker and
Walker, 2013; Goedert, 2015; Giacomelli et al., 2017). In addition,
the occurrence of hybrid oligomers (“heteroaggregates”) has been
shown in both patients’ brains and cellular models (Parnetti et al.,
2013; Sengupta et al., 2015; Andersen et al., 2017; Daniele et al.,
2017; Giacomelli et al., 2017). In this respect, the levels of the so
called “aging-related proteins” have been monitored recently in
human red blood cells (RBCs), where α-syn has been shown to
interact with Aβ or tau healthy subjects (Daniele et al., 2017).
Accumulation of toxic, possibly infectious, protein aggregates
induces a cascade of events, such as excessive inflammation,
the production of ROS, apoptosis and neuronal loss (Hinault
et al., 2006). Moreover, proteinopathy and oxidative stress,
together with mitochondrial dysfunction, represent “interacting
damage pathways” that culminate in cellular degeneration. In
fact, ROS have been demonstrate to enhance the aggregation,
of neurodegeneration-related proteins that, in turn, may interact
with transition metals or other components to generate further
ROS (Snead and Eliezer, 2014; Xiang et al., 2015).
Regular physical activity has been emerging as a pivotal
factor in counteracting cellular oxidative stress, by exerting anti-
inflammatory actions (Sallam and Laher, 2016), up-regulating
the enzymatic antioxidant system (Voss et al., 2013; Radak
et al., 2016), but also increasing neurogenesis and proteolytic
degradation of misfolded proteins (Johnson and Mitchell, 2003;
Lazarov et al., 2005; Radak et al., 2013). Consequently, it is
not surprisingly that exercise has been shown also to impact
protein oligomerization; for example, running has been related
to a reduced Aβ deposition and tau phosphorylation in mouse
brains (Brown et al., 2013; Baldacci et al., 2016; Tapia-Rojas
et al., 2016; Koo et al., 2017). Recently, data on such beneficial
effects have been emerging in human subjects at a peripheral
level, too (DeMattos et al., 2001; Eisele et al., 2010; Brown et al.,
2013). In fact, protein accumulation and aggregation has been
demonstrated to reach the cerebrospinal and peripheral fluids,
too (Tokuda et al., 2010). Therefore, biological changes and
putative peripheral biomarkers can be exploited in tissue other
than the brain.
In this respect, we have demonstrated that aging-related
proteins and in particular α-syn heteromeric interactions with
Aβ or tau can be modulated by both oxidative stress and physical
exercise (Daniele et al., 2017).
Abbreviations: AOC, antioxidant capacity; Aβ, β-amyloid1−42; α-syn,
α-synuclein; NDs, neurodegenerative diseases; ROS, reactive oxygen species;
SD, standard deviation; TBS-T, Tris buffered saline tween20.
In order to understand if a specific distribution of misfolded
proteins can occur in other blood cells, herein the presence
and levels of aging-related proteins were investigated in platelets
isolated from human subjects, grouped by their level of physical
exercise (i.e., athletes and sedentary subjects) and their age
(young and older subjects). Specifically, α-syn heterocomplexes
with Aβ or tau were measured to unveil their presence and
putative pathogenic role in platelets (Veitinger et al., 2014).
Moreover, plasma AOC, the primary marker of oxidative stress
in aging-related pathologies (Pandey and Rizvi, 2010), was
quantified in the same cohort and correlated to the grade of
physical exercise.
MATERIALS AND METHODS
Study Population and Setting of the
Study
Endurance athletes (N = 45, ATHL, mean age 45.2 ± 13.0 years)
and age-sex-matched sedentary volunteers (N = 58, SED, mean
age 47.6 ± 14.4 years) were recruited from the Sport Medicine
Unit of the Department of Clinical and Experimental Medicine
of the University of Pisa (Table 1).
Major inclusion criteria were as followed: total plasma
cholesterol ranging from 3.1 to 5.8 mmol/L, HDL cholesterol
from 0.67 to 1.9 mmol/L, plasma triglycerides from 0.34 to
1.7 mmol/L, body mass index lower than 30 kg/m2, diastolic
arterial blood pressure lower than 90 mmHg and systolic arterial
blood pressure lower than 140 mmHg (Daniele et al., 2017).
Subjects were excluded if they had smoking habits or received
drug treatments within the previous 2 months (Daniele et al.,
2017).
Aerobic fitness was evaluated with a maximal graded cycle
ergometry test performed by a cardiologist blinded to the other
data (Whaley et al., 2006). Blood pressure and the rate of
perceived exertion (RPE) were assessed at the end of each
step. The 15-point Borg RPE scale (Borg, 1982; Hamer and
Slocombe, 1997) was used to evaluate the level of intensity for
each participant (Daniele et al., 2017). The scale ranges from 6 to
20, with 6 corresponding to no exertion at all, 7.5 to extremely
light, 9 to very light, 11 to light, 13 to somewhat hard, 15 to hard,
17 to very hard, 19 to extremely hard, and 20 to maximal exertion.
The enrolled healthy subjects were divided into younger
(≤50 years), older (>50 years), athletes (ATHL) and sedentary
(SED) subgroups (Table 1 and see “Results” section). The time
period between the last exercise bout and blood sampling was at
least 48 h.
This study was approved by the Ethics Committee of the
Great North West Area of Tuscany (271/2014 to FF) and it was
carried out in accordance with the Declaration of Helsinki. All
subjects gave informed consent to participate in the study. Fully
informed consent was obtained from each subject entering the
study (Daniele et al., 2017).
Plasma and Platelet Collection
Whole blood from healthy volunteers was collected into a tube
containing EDTA as an anticoagulant. The plasma was separated
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TABLE 1 | Descriptive analysis of the total population and of the subgroups.
Number of subjects (N) Age (y) BMI Heart rate Physical activity level
Young subjects 55 36.1 ± 8.8 23.2 ± 1.9 55.7 ± 3.8 9.94 ± 3.92
Older subjects 48 58.4 ± 7.4 23.7 ± 2.1 59.3 ± 5.8 8.90 ± 3.20
ATHL 45 45.2 ± 13.0 23.8 ± 1.9 50.6 ± 3.8 13.2 ± 2.2∗
SED 58 47.6 ± 14.4 24.0 ± 1.6 62.3 ± 5.2 6.61 ± 0.64
The data are the mean ± SD. BMI, body mass index; ATHL, athletes, SED, sedentary. Differences between groups (i.e., young vs. older and ATHL vs. SED) were evaluated
by One-way ANOVA followed by a Kruskal–Wallis post hoc test. P-values were adjusted with Sidak’s multiple comparison test. ∗P < 0.001 ATHL vs. SED subjects.
by centrifugation (200× g at 4◦C for 10 min), and then stored at
−80◦C until use.
To obtain platelets, platelet-rich plasma was collected and
centrifuged at 7000 × g for 10 min at 4◦C. The platelet pellets
were washed with 0,83% NH4Cl and centrifuged at 1500 × g.
Then, the pellet was washed with 3 ml of PBS, centrifuged and
frozen at−20◦C.
Co-immunoprecipitation and Western
Blotting Analysis
The α-syn, tau and Aβ expression was assessed as described
previously (Daniele et al., 2017). In brief, platelets (1,8 mg of
proteins) were lysed with RIPA buffer (Costa et al., 2013) and
then resolved by SDS-PAGE (8.5%). Platelets were incubated
with primary antibodies to α-syn (α/β-synuclein N-19, SC-7012,
Santa Cruz Biotechnology), tau (H-150 SC-5587, Santa Cruz
Biotechnology) or Aβ (β-amyloid H-43 SC-9129, Santa Cruz
Biotechnology) overnight at 4◦C (Daniele et al., 2017). The
primary antibodies were detected using peroxidase- conjugated
secondary antibodies and a chemioluminescent substrate (ECL,
Perkin Elmer).
To verify α-syn interaction with tau or Aβ, a co-
immunoprecipitation assay was employed (Costa et al., 2013;
Daniele et al., 2017). Briefly, 0.5 mg of platelet lysate proteins
was probed overnight under constant rotation with an anti-
α-syn antibody (5 µg/sample), and then immunoprecipitated
with protein A-Sepharose. After extensive washing, the
immunocomplexes were re-suspended in Laemmli solution,
resolved by SDS-PAGE and probed overnight with primary
antibodies to α-syn (input), tau or Aβ as above described
(Daniele et al., 2017).
Detection of Total α-synuclein
Total α-syn was detected in platelets, as previously described
(Foulds et al., 2011; Daniele et al., 2017). In brief, wells
were coated using a α-syn full length antibody (sc-10717,
Santa Cruz Biotechnology), and non-specific sites were blocked
using Bovine Serum Albumine (BSA). Platelet samples (32 µg
proteins/100 µl) were added to the wells for 2 h at 25◦C.
In parallel, recombinant aliquots of α-syn were tested to
create a standard curve. After extensive washing, wells were
incubated with a different α-syn antibody (Santa Cruz,
sc-12767), and subsequently with an anti-mouse-HRP antibody
(Daniele et al., 2017). The samples were washed with PBS-T
(phosphate buffered saline containing 0.01% Tween 20),
and incubated with the enzyme substrate TMB (3,3′,5,5′-
tetramethylbenzidine, Thermo Scientific). Absorbance values
were read at 450 nm.
Detection of Total Aβ
Aβ levels in platelets were assessed using an immunoenzymatic
assay, as previously described (Pesini et al., 2012; Daniele
et al., 2017). A specific anti-Aβ antibody (Santa Cruz, sc-
9129) was used for 96-well coating at 4◦C. After extensive
washing with PBS-T, non-specific sites were blocked with 1%
BSA. Platelets (80 µg proteins/100 µl) were added to each
well and incubated at 25◦C for 1 h. After extensive washing
with PBS-T, samples were detected using the polyclonal Aβ
antibody (sc-5399, Santa Cruz Biotechnology). The standard
curve was achieved using solutions of recombinant human
Aβ protein at eight different concentrations (Daniele et al.,
2017).
Detection of Total Tau
Tau levels in platelets were determined using an
immunoenzymatic assay, as previously described (Pesini
et al., 2012; Daniele et al., 2017). In brief, platelets (32 µg
proteins/100 µl) were added to each well pre-coated with a
specific anti-tau antibody (Santa Cruz, sc-32274). Then, samples
were probed with a different tau antibody (sc-5587, Santa Cruz
Biotechnology). In parallel, solutions of recombinant human tau
protein were used to obtain a standard curve.
Detection of α-syn-Aβ Heterocomplexes
The degree of α-syn-Aβ interactions were quantified, as
previously described (Daniele et al., 2017). In brief, standard
α-syn-Aβ were prepared in 2 mM sodium dodecyl sulfate (SDS)
in parafilm-sealed tubes at 37◦C for 36 h in an “Eppendorf
Thermomixer” with continuous mixing (500 rpm) (Mandal et al.,
2006; Daniele et al., 2017).
Platelets (800 µg/sample) were added to wells pre-coated
with the β-amyloid H-43 antibody (1:100, sc-9129, Santa Cruz
Biotechnology) at 25◦C for 2 h. Non-specific sites were blocked
with 1% BSA for 30 min at 37◦C. The degree of α-syn bound
to Aβ was detected using a specific antibody against α-syn
(sc-12767, Santa Cruz Biotechnology), and subsequently an
appropriate HRP-conjugated antibody (Daniele et al., 2017).
Relative concentration of α-syn/Aβ complexes were calculated
according to the standard curve obtained in each microplate
(Daniele et al., 2017).
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Detection of α-syn-Tau Heterocomplexes
Standard samples of α-syn-tau were prepared in 2 mM
SDS (Daniele et al., 2017). Wells were pre-coated with anti-
α-syn antibody (1:100, sc-7012, Santa Cruz Biotechnology) and
incubated with platelet samples (800 µg/sample) at 25◦C for
2 h. Non-specific sites were blocked with 1% BSA for 30 min
at 37◦C. The wells were probed with a specific tau antibody
(sc-5587, Santa Cruz Biotechnology), and subsequently with the
appropriate HRP-conjugated antibody (Daniele et al., 2017).
Relative concentration of α-syn/tau complexes were calculated
according to the standard curve obtained in each microplate
(Daniele et al., 2017).
Total Oxyradical Scavenging
Capacity (TOSC) Assay
The plasma antioxidant capability (AOC) was assessed by the
TOSC assay, a gas chromatographic assay for determining
oxyradical scavenging capacity of biological fluids (Winston
et al., 1998; Regoli and Winston, 1999; Daniele et al.,
2017). Peroxynitrite was generated from the decomposition of
SIN-1 (3-morpholinosyd-nonimine N-ethylcarbamide) in the
presence of 0.2 mM KMBA [α-cheto-γ-(methylthiol)butyric
acid], 100 mM potassium phosphate buffer, pH 7.4, and 0.1 mM
DTPA (Diethylene Triamine Penta Acetic Acid), at 35◦C. The
concentration of SIN-1 was varied to achieve an ethylene
yield equivalent to the iron–ascorbate and ABAP systems.
Reactions with 0.2 mM KMBA were carried out in 10 ml vials
sealed with gas-tight Mininert1 valves (Supelco, Bellefonte, PA,
United States) in a final volume of 1 ml. TOSC values were
quantified from the equation TOSC = 100 − (SA/CA × 100),
where SA and CA, are respectively, the area under the curve
(AUC) for sample and control reaction. A TOSC value of 0
corresponds to a sample with no scavenging capacity (Regoli
and Winston, 1999; Franzoni et al., 2006; Daniele et al.,
2017).
Statistical Analysis
Data are expressed as mean value ± SD. The population
included in this study presented a normal distribution for
age. Differences between groups (i.e., young vs. older and
ATHL vs. SED) were evaluated by One-way ANOVA followed
by a Kruskal–Wallis post hoc test. P-values were adjusted
with Sidak’s multiple comparison test. Correlation between
variables was determined by simple linear regression analysis,
while covariate analysis was performed by partial correlation
matrix. All statistical procedures were performed using the
StatView program (Abacus Concepts, Inc., SAS Institute, Cary,
NC, United States) (Franzoni et al., 2005; Daniele et al.,
2017).
RESULTS
Descriptive Statistics
The whole cohort (N = 103) was divided in four subgroups
(young SED, young ATHL, older SED and older ATHL),
FIGURE 1 | Presence of α-syn, Aβ, tau, and their heterocomplexes in
platelets. (A) Cell lysates obtained from platelets were subjected to western
blot analysis using antibody against α-syn, Aβ, or tau. GAPDH was the loading
control. (B) Cell lysates obtained from platelets were immunoprecipitated with
an anti-α-syn antibody and then immunoblotted with an α-syn, Aβ, or tau
specific antibodies. One representative western blot is presented for each
condition.
whose clinical characteristics are reported in Table 1. The
mean age of young and older cohort was of 36.1 ± 8.8
and 59.4 ± 7.4, respectively. No significant differences in age,
sex and body mass index (BMI) was found between ATHL
and SED. As expected, the level of physical activity was
significantly higher in the ATHL group than the SED group
(P < 0.001).
Expression of α-syn, tau, Aβ Proteins and
of α-syn-Tau and α-syn-Aβ
Heterocomplexes in Human Platelets
Western blotting analysis was used to investigate the presence
of α-syn, tau and Aβ proteins in platelets isolated from healthy
subjects. As depicted in Figure 1A, the anti-α-syn antibody
produced two bands at 15 and 30 kDa (Figure 1A, middle
panel), matching α-syn (Bartels et al., 2011), whereas the anti-
tau antibody recognized three immunoreactive bands ranging
between 55 and 74 kDa (Buée et al., 2000). These data
confirm that platelets have detectable levels of tau and α-syn
(Nakai et al., 2007; Neumann et al., 2011). Finally, the anti-
Aβ antibody recognized two bands at 5 and 15 kDa proteins
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(Figure 1A, bottom panel), corresponding to Aβ monomeric and
oligomer forms, respectively (Cerf et al., 2009; Nielsen et al.,
2013).
Next, α-syn interaction with Aβ and tau in platelets was
verified using a co-immunoprecipitation-western blotting assay
(Figure 1B). In particular, cell lysates were immunoprecipitated
using an anti-α-syn antibody, and then an immunoblot analysis
was performed using an anti-tau or anti-Aβ antibody. In
parallel, immunoprecipitates were blotted with the same α-syn
antibody.
As expected, in α-syn immunoprecipitates (Figure 1B,
upper panel), two bands of 15 and 30 kDa were recognized
by the anti-α-syn antibody. When α-syn immunoprecipitates
were probed with an anti-tau antibody (Figure 1B, middle
panel), three immunoreactive bands ranging between 55
and 74 kDa were immunodetected (Buée et al., 2000).
Additional bands, with a molecular weight lower than 50 kDa,
could be related to truncated or cleaved forms of tau
containing the C-terminal region (Santpere et al., 2006; Daniele
et al., 2017). Finally, the Aβ immunoblotting performed
on α-syn immunoprecipitates (Figure 1B, bottom panel)
revealed multiple bands indicating monomeric and oligomeric
Aβ forms (Figure 1B) (Nielsen et al., 2013). These data
demonstrated that α-syn physically interacted with Aβ and tau
in platelets, as previously demonstrated in RBCs (Daniele et al.,
2017).
α-syn Quantitative Levels in Human
Platelets
α-syn concentrations were determined in platelets isolated from
103 healthy subjects (Table 2). As depicted in Figure 2A, older
subjects presented significant lower α-syn levels with respect to
young ones (young vs. older, P = 0.0168), suggesting that α-syn
may decline with age in platelets. In contrast, no significant
differences in total α-syn levels in platelets were noticed between
ATHL and SED (P= 0.2052, Figure 2A), suggesting that physical
exercise modulated poorly the platelet pool of α-syn.
Aβ Quantitative Levels in Human
Platelets
Aβ platelet levels showed comparable levels between young and
older subjects (young vs. older, P = 0.5369, Figure 2B), as well as
between ATHL and SED (ATHL vs. SED, P= 0.2240, Figure 2B).
These data suggest that age and physical exercise poorly
modulate Aβ concentrations in platelets.
Tau Quantitative Levels in Human
Platelets
Similarly to what observed for Aβ, the platelet concentrations of
tau showed comparable levels between young and older subjects
(Figure 2C, young vs. older, P = 0.1877).
On the other hand, ATHL showed significantly lower tau levels
in platelets with respect to SED in the whole population (total
ATHL vs. total SED, P = 0.0048, Figure 2C). These data suggest
that tau accumulation in platelets is modulated by physical
exercise.
α-syn-Tau and α-syn-Aβ Quantitative
Levels in Human Platelets
Finally, the concentrations of α-syn-Aβ and α-syn-tau
were measured in platelets using a previously standardized
immunoenzymatic assay (Daniele et al., 2017).
As demonstrated in RBCs, platelet α-syn-Aβ or α-syn-
tau levels did not differ between young and elderly subjects
(P = 0.6734 and P = 0.7762, respectively, Figures 2D,E).
The degree of α-syn interaction with Aβ in platelets was
comparable between ATHL and SED (P = 0.9962, Figure 2D).
In contrast, the ATHL subjects presented significantly lower
levels of platelet α-syn-tau with respect to SED, regardless of
age (Figure 2E, ATHL vs. SED: P = 0.0085), suggesting that
α-syn-tau levels in platelets can be modulated by physical activity.
Correlation of ND-Related Proteins with
Age
Consistent with the data depicted in Figure 2A, an inverse
correlation with age was evidenced for total α-syn in the whole
cohort (total cohort: P = 0.0439, R2 = 0.045, Figure 3A).
Conversely, a significant positive correlation between Aβ
levels in platelets and age was evidenced in the whole population
(P = 0.0487, R2 = 0.038, Figure 3B) and in SED (P = 0.0488,
R2 = 0.062, Figure 3C).
Surprisingly, significant inverse correlation between age
and platelet α-syn-Aβ concentrations was found in ATHL
(P= 0.0093, R2 = 0.225 Figure 3D) but not in SED (P= 0.1804).
In contrast, α-syn-tau levels in platelets inversely correlated with
age in SED (P = 0.0493, R2 = 0.056; Figure 3E) but not in ATHL
(P = 0.1804).
Plasma Antioxidant Capacity (AOC)
in Healthy Subjects
A TOSC assay was used to determine the AOC toward
peroxynitrite derivatives in plasma from healthy subjects
(Table 2); higher mean levels from this assay are related to a better
antioxidant capability (Daniele et al., 2017).
Young and older subjects showed comparable TOSC values in
the total population (young vs. older, P = 0.3423, Figure 4A).
Nevertheless, TOSC values showed an inverse correlation with
age in the total population (P = 0.0315, R2 = 0.045, Figure 4B).
Antioxidant capacity toward peroxynitrite derivatives was
significantly higher in ATHL group with respect to SED
(ATHL vs. SED, P < 0.0001). Consistent with these findings,
peroxynitrite TOSC values showed a direct correlation with the
level of physical activity (Figures 4C–E, total cohort: P < 0.0001,
R2 = 0.317; young cohort: P < 0.0001, R2 = 0.406; older cohort:
P = 0.0002, R2 = 0.26). These results confirm that physical
exercise can enhance plasma AOC in humans (Daniele et al.,
2017).
Correlation of Aging-Related Proteins
with Plasma AOC
Plasma AOC toward peroxynitrite derivatives did not show any
significant correlations with the platelet levels of tau (P= 0.3378),
Aβ (P = 0.4195), total α-syn (P = 0.3704) or α-syn-Aβ
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TABLE 2 | Total Oxyradical Scavenging Capacity (TOSC) values against peroxynitrite derivatives; concentrations of total α-syn, Aβ, α-syn/Aβ, tau, and α-syn/tau
(as ng/mg of total protein) in the indicate subgroups.
TOSC values peroxynitrite Total α-syn Aβ α-syn/Aβ Tau α-syn/tau
Young subjects 18.0 ± 2.0 362 ± 275 560 ± 484 248 ± 173 170 ± 102 159 ± 99
Older subjects 17.6 ± 2.7 235 ± 132## 650 ± 500 280 ± 233 214 ± 107 176 ± 161
ATHL 19.3 ± 1.8 287 ± 219 697 ± 535 261 ± 197 136 ± 122 114 ± 89
SED 16.7 ± 2.1∗∗∗ 372 ± 284 552 ± 470 267 ± 215 218 ± 182∗ 192 ± 169∗
The values are expressed as mean ± SD. ATHL, athletes, SED, sedentary. Differences between groups (i.e., young vs. older and ATHL vs. SED) were evaluated by
One-way ANOVA followed by a Kruskal–Wallis post hoc test. P-values were adjusted with Sidak’s multiple comparison test. ∗P < 0.05, ∗∗∗P < 0.001 vs. the respective
group of ATHL; ##P < 0.01 vs. the respective group of young subjects.
(P = 0.8515). Interestingly, α-syn-tau levels showed an inverse
correlation with TOSC values in the whole cohort (P = 0.0420,
R2 = 0.049, Figure 5A), suggesting that α-syn interaction with
tau in platelets can be related to plasma AOC.
Moreover, an inverse correlation was evidenced between
platelet Aβ levels and TOSC values in the SED population
(P = 0.0333, R2 = 0.099, Figure 5B), suggesting that Aβ
accumulation in platelets may be related to plasma AOC in the
presence of a low level of physical activity.
Correlation of Aging-Related Proteins
with Physical Activity
The physical activity level was not significantly related to
the platelet levels of tau (whole cohort: P = 0.4107; older
group: P = 0.1903), Aβ (whole cohort. P = 0.1694; older
group: P = 0.7456; young group: P = 0.1068), or α-syn-Aβ
(whole cohort: P = 0.9880; older group: P = 0.1033; young
group: P = 0.1291). Conversely, total α-syn concentrations were
inversely related to the level of physical activity in the older group
(P = 0.0429, R2 = 0.040, Figure 5C), but not in the total cohort
(whole cohort: P = 0.2688) or in the young one (P = 0.3072).
Interestingly, α-syn-tau concentrations showed an inverse
correlation with the level of physical activity, regardless of age
(Figures 5D–F, whole cohort: P = 0.0429, R2 = 0.040; older
group: P = 0.0157, R2 = 0.169; young group: P = 0.0045,
R2 = 0.022). These data are consistent with those reported in
Figure 3E, and confirm that α-syn interaction with tau in platelets
can be modulated negatively by physical exercise.
Covariate Analysis
The partial correlation analysis (Table 3) showed that the TOSC
values toward peroxynitrite derivatives were influenced primarily
from age. In turn, TOSC values predicted the platelet α-syn-tau
levels.
Interestingly, among all the analyzed variables, α-syn-Aβ
concentrations in platelets were significantly decreased by
physical exercise.
DISCUSSION
In the present paper, aging-related proteins were detected
in platelets of healthy subjects (N = 103), and correlated
to the subject AOC and to the level of physical exercise.
The main findings of this work are the follows: (i) α-syn
declined in older subjects, whereas Aβ directly correlated
with increasing age; (ii) total α-syn and Aβ concentrations
showed an inverse correlation with AOC toward peroxynitrite
derivatives in elderly and sedentary subjects, respectively; (iii)
tau levels decreased in athletes; (iv) α-syn directly interacted
with Aβ and tau in platelets; (v) α-syn interaction with
tau was inversely related to peroxynitrite AOC and to the
level of physical activity. These results suggest that α-syn
heterocomplexes, particularly with tau, could represent
novel indicators to monitor aging-related proteins in
platelets.
The loss of protein homeostasis that physiologically occur
with age is characterized by the accumulation of at least one
particular protein into a well-organized fibrillary structure called
amyloid (Chiti and Dobson, 2006). In the case of brain aging,
misfolded proteins can reach the blood compartment as the result
of oligomer transfer across the blood brain barrier (DeMattos
et al., 2001; Zlokovic, 2004; Eisele et al., 2010).
The accumulation and toxicity of aging-related proteins have
been demonstrated to increase with raising oxidative stress in
transgenic animal models and cultured cells (reviewed in Zhao
and Zhao, 2013; Alavi Naini and Soussi-Yanicostas, 2015), leading
a critical vicious circle.
On the other hand, several data support the notion that
regular physical activity counteracts oxidative stress (Johnson
and Mitchell, 2003; Lazarov et al., 2005; Radak et al., 2013)
and reduces protein oligomerization in mouse brains (Brown
et al., 2013; Baldacci et al., 2016; Tapia-Rojas et al., 2016; Koo
et al., 2017). Recently, data on such beneficial effects have been
emerging in human subjects too (DeMattos et al., 2001; Eisele
et al., 2010; Brown et al., 2013).
Recently, we have investigated the influence of physical
activity and antioxidant capability on the accumulation of aging-
related proteins in human RBCs (Daniele et al., 2017), which
represent a good peripheral model to monitor oxidative stress
(Kim et al., 2008; Mohanty et al., 2014).
Herein, to unveil putative differences among the blood pools
of aging-related proteins, the aforementioned parameters were
examined in platelets, too.
To this purpose, a cohort of 103 healthy subjects was
enrolled in the present study. Platelets were isolated from
peripheral blood, and the levels of α-syn, Aβ tau, and of their
heterocomplexes, were measured by immunoenzymatic assays,
and related to the extent of the antioxidant capability or of
physical exercise.
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FIGURE 2 | Quantitative detection of aging-related proteins in platelets. (A–E) Platelet levels of total α-syn (A), Aβ (B), tau (C), α-syn/Aβ (D), and α-syn/tau, (E) in
young, older, ATHL and SED subjects (mean ± SD). Lysates obtained from platelets were subjected to specific immunoassay, as described in the Section “Materials
and Methods.”. Differences between groups (i.e., young vs. older and ATHL vs. SED) were evaluated by One-way ANOVA followed by a Kruskal–Wallis post hoc test.
P-values were adjusted with Sidak’s multiple comparison test: ∗P < 0.05, ∗∗P < 0.01 between the indicated subgroups.
In our cohort, the plasma AOC was evaluated against
peroxynitrite derivatives, in order to extend the data obtained
toward hydroxyl and peroxyl species (Daniele et al., 2017).
TOSC values confirmed an inverse correlation with age in the
total population and in the sedentary cohort, as reported
previously (Inal et al., 2001; Goraca, 2004). Moreover,
AOC toward peroxynitrite derivatives correlated directly
with the level of physical activity, regardless of subjects’
age. These results confirm that regular physical exercise
can enhance plasma AOC in humans (Farah et al., 2013;
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FIGURE 3 | Correlation between aging-related proteins and age. (A) Correlation analysis between Aβ concentrations in platelets and age in whole and sedentary
cohort (B,C) Correlation analysis between Aβ concentrations in platelets and age in whole and sedentary cohort. (D) Correlation analysis between α-syn/Aβ
concentrations in platelets and age in the ATHL cohort. (E) Correlation analysis between α-syn-tau and age in the SED cohort. Correlation between variables was
determined by simple linear regression analysis, using the StatView program (Abacus Concepts, Inc., SAS Institute, Cary, NC, United States). P and R2 values
obtained for each correlation are reported in the respective panel.
Sallam and Laher, 2016; Daniele et al., 2017), and that the
latter parameter is independent form the examined radical
specimen.
Then, platelets were confirmed to express the age-related
proteins α-syn, Aβ, tau (Cerf et al., 2009; Bartels et al., 2011;
Neumann et al., 2011; Nielsen et al., 2013).
The levels of total α-syn decreased with age in the whole
population, consistent with the data reported for α-syn in RBCs
and plasma of healthy subjects or PD patients (Mohanty et al.,
2014; Wang et al., 2015; Koehler et al., 2015; Zhao et al., 2016).
Conversely, platelet Aβ levels directly correlated with age, as
previously reported in RBCs (Kiko et al., 2012; Daniele et al.,
2017). Considering the role of Aβ in the thrombosis formation
(Shen et al., 2008), such age-dependent accumulation in human
platelets could account, at least in part, for the enhanced
thrombosis risk in the elderly.
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FIGURE 4 | Determination of plasma AOC in human subjects. (A) Plasma total oxyradical scavenging capacity (TOSC) against peroxynitrate derivatives in young,
older, ATHL and SED subjects (mean ± SD). Differences between groups (i.e., young vs. older and ATHL vs. SED) were evaluated by One-way ANOVA followed by a
Kruskal–Wallis post hoc test. P-values were adjusted with Sidak’s multiple comparison test: ∗∗∗P < 0.001 between the indicated subgroups. (B–E) Correlation
analysis between TOSC values against peroxynitrate derivatives and age or level of physical activity, expressed as physical activity level. Correlation between
variables was determined by simple linear regression analysis, using the StatView program (Abacus Concepts, Inc., SAS Institute, Cary, NC, United States). P and R2
values obtained for each correlation are reported in the respective panel.
Aβ concentrations inversely correlated with plasma AOC
in SED, suggesting this protein as a marker of oxidative
stress in peripheral cells. Consistent with this hypothesis,
blood Aβ levels have been demonstrated to positively
correlate with an oxidative stress marker (Kiko et al.,
2012).
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FIGURE 5 | Correlation between ND-related proteins and TOSC values against peroxynitrite derivatives or physical activity level. (A) Correlation analysis between
α-syn/tau concentrations in platelets and TOSC values against peroxynitrite derivatives in the total cohort. (B) Correlation analysis between Aβ concentrations in
platelets and TOSC values against peroxynitrite derivatives in SED cohort. (C) Correlation analysis between total α-syn concentrations in platelets and physical
activity level in older cohort. (D–F) Correlation analysis between α-syn/tau concentrations in platelets and physical activity level in total (D), older (E) and young
(F) cohort. Correlation between variables was determined by simple linear regression analysis, using the StatView program (Abacus Concepts, Inc., SAS Institute,
Cary, NC, United States). P and R2 values obtained for each correlation are reported in the respective panel.
Then, the influence of physical exercise in ATHL and SED
was examined. No significant differences between ATHL and
SED were found for total α-syn levels in platelets, suggesting
that platelet α-syn concentrations are poorly related to physical
activity. In contrast, exercise has been shown to induce a
significant reduction in the brain accumulation of α-syn (Jang
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TABLE 3 | Partial correlation matrix between the analyzed variables.
Age Physical activity level TOSC values peroxynitrite α-syn-Aβ Aβ Total α-syn α-syn-tau Tau
Age 1,000 −0,185 −0,001 0,070 0,181 −0,189 0,016 −0,037
15 point Borg RPE scale −0,185 1,000 0,520 −0,007 0,329 −0,090 −0,137 −0,027
TOSC values peroxynitrite −0,001 0,520 1,000 0,053 −0,161 −0,019 −0,029 −0,081
α-syn-Aβ 0,070 −0,007 0,053 1,000 −0,164 −0,017 −0,073 −0,129
Aβ 0,181 0,329 −0,161 −0,164 1,000 −0,057 −0,272 −0,361
Total α-syn −0,189 −0,090 −0,019 −0,017 −0,057 1,000 −0,180 −0,165
α-syn-tau 0,016 −0,137 −0,029 −0,073 −0,272 −0,180 1,000 −0,500
Tau −0,037 −0,027 −0,081 −0,129 −0,361 −0,165 −0,500 1,000
et al., 2017), and α-syn levels in RBCs have been found
significantly different in ATHL and SED, especially in the elderly
cohort (Daniele et al., 2017). These data may suggest that the
correlation between brain and peripheral fluid is cell-dependent,
and, specifically, may be explained considering that α-syn is
mainly expressed in RBCs (Barbour et al., 2008).
The modest influence of exercise on the platelet pool of
protein was confirmed for Aβ in the present study. In contrast,
significant differences have been reported in RBCs (Daniele et al.,
2017) and in plasma (Brown et al., 2013) of healthy subjects.
Consistent with the latter’s data, voluntary exercise has been
recently shown to promote glymphatic clearance of Aβ in aged
mice.
In this respect, a huge amount of literature data (reviewed
in Ebrahimi et al., 2017), report the beneficial effects of
physical activity on cognitive function and memory, both in
transgenic mice of neurodegeneration and in patients affected
by Alzheimer’s disease or Mild Cognitive Impairment. Globally,
the comparison between the data obtained in this study and
literature datasuggest that a different modulation of the Aβ
platelet pool may occur with respect to other central or peripheral
fluids. Further subjects will be needed to confirm the data on
Aβ accumulation in blood cells and to understand the biological
significance of these findings, both in healthy subject and in
patients affects by NDs.
Interestingly, ATHL showed significantly lower tau levels
in platelets with respect to SED in the whole population,
suggesting that tau accumulation in platelets is modulated by
physical exercise. Analogous data have been reported in RBCs
of healthy subjects (Daniele et al., 2017). Similarly, aerobic
exercise has been related to a reduction of phosphorylated tau
protein in cerebrospinal fluid in older adults with mild cognitive
impairment (Baker et al., 2015) and in transgenic mice (Ohia-
Nwoko et al., 2014).
Next, the presence of α-syn associated to Aβ or tau was
investigated in human platelets. α-syn was demonstrated
to co-localize with tau and Aβ in platelets, as previously
demonstrated in neurons or in cultured cells (Jensen
et al., 1998; Masliah et al., 2001; Giasson et al., 2003;
Lee et al., 2004; Mandal et al., 2006; Tsigelny et al., 2008;
Badiola et al., 2011) and in RBCs (Daniele et al., 2017). As
demonstrated in the latter cells, α-syn-Aβ or α-syn-tau levels
in platelets did not differ between young and elderly subjects.
Nevertheless, an inverse correlation between the platelet
concentrations of α-syn heterocomplexes and age was found in
ATHL. These data suggest that regular exercise influences the
accumulation of α-syn heterocomplexes in an age-dependent
manner.
α-syn-tau levels showed an inverse correlation with TOSC
values and with the level of physical activity in the whole
cohort, regardless of age, demonstrating that α-syn interaction
with tau in platelets can be modulated by both AOC and
physical exercise. Interestingly, in RBCs physical exercise has
been shown to regulate α-syn interaction with Aβ rather than
with tau (Daniele et al., 2017). These findings may suggest
that regular exercise can exert a different modulation on α-syn
heteromeric interaction, depending on the protein localization in
blood.
On the light of our data, the correlation between antioxidant
capability, regular activity and aging-related proteins in platelets
seems to be modest with respect to that reported in brain or
RBCs. This may probably account for the higher susceptibility
to oxidative stress that has been reported for RBCs with respect
to platelets. Further investigations could compare, in the various
blood cells, the expression and activity of the enzyme related
to the antioxidant system or the production and trafficking
of aging-related proteins. Moreover, in such future studies the
conformational state of the measured proteins will be explored.
In interpreting our data, it should be considered that these
findings were obtained in platelets of a cohort of healthy
subjects. The changes in the levels of aging-related proteins
and α-syn heterocomplexes could not have a prognostic role in
neurodegeneration, yet.
CONCLUSION
The positive effect of plasma AOC and regular physical exercise
on the accumulation of aging-related proteins in platelets was
confirmed partially in the present paper. Most importantly, for
the first time, α-syn was demonstrated to interact with Aβ and
tau human platelets. In particular, this study evidenced the great
modulation of α-syn interaction with tau rather than with Aβ in
human platelets, probably because of the main presence of tau in
these cells with respect to RBCs. These data open the way to new
studies aimed at establishing the putative correlation between
peripheral and central levels of α-syn heterocomplexes and their
role in pathological conditions.
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